arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

InfuSystem Holdings, Inc

INFU
$12.46 ▲ +0.56 (+4.71%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
18 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Neutral
auto_awesome

Analytical Summary

InfuSystem Holdings, Inc shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $257.4M
Dividend Yield
Revenue Growth 6.4%
Op. Margin 8.3%
ROIC 9.7%
FCF / Share $1.15
Trailing P/E 38.9x
Price / Book 4.4x
FCF Yield 9.3%
Debt / Equity 0.34
info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$143.44M
↑ +6.4%
Net Income Profit after all expenses
$6.63M
↑ +182.6%
Operating Margin Operating profit as % of sales
8.3%
↑ +62.6% 52th
FCF / Share Free cash flow per share
$1.15
↑ +26.8%
Long-Term Debt Long-term obligations
$19.62M
↓ -17.8%

Health Breakdown

Profitability
59
Returns
72
Financial Health
71
Cash Quality
93

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters